Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Urinary Tract Infection

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 39 articles: HTML format

Single Articles

September 2025
1. ALSHANQEETI S, Coffey K, Mcdermott K, de Guzman A, et al
   Comparing generative artificial intelligence vs. experts for detection of catheter-associated urinary tract infection (CAUTI).
   Clin Infect Dis. 2025 Sep 9:ciaf486. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
2. RUFFIN F, Sutton KN, Miller J, Lane H, et al
   A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection.
   Clin Infect Dis. 2025;81.
   PubMed     Abstract available
   
   
   
3. MINTER DJ, Wang TW, Rader A, Barton KD, et al
   A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections.
   Clin Infect Dis. 2025;81.
   PubMed     Abstract available
   
   
   July 2025
4. CLAEYS KC, Brown CH, Pineles L, Evans CT, et al
   Implementation of Diagnostic Stewardship to Improve Urinary Tract Infection Antibiotic Use Across Three Medical Centers.
   Clin Infect Dis. 2025 Jul 26:ciaf411. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2025
5. LODISE TP, Das AF, Frimodt-Moller N, Gupta K, et al
   Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis.
   Clin Infect Dis. 2025 Jun 26:ciaf280. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. LARACY JC, Chan JL, Kodama R, Yan J, et al
   Improving Urinary Tract Infection Diagnostics in Oncology: Reliability of Reflex Urine Culture in Immunosuppressed Neutropenic and Non-neutropenic Cancer Patients.
   Clin Infect Dis. 2025;80:969-974.
   PubMed     Abstract available
   
   
   
7. RAMIREZ-OLIVENCIA G, Fernandez Tomas M
   Considerations about patients with Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors treatment in recurrent urinary tract infections.
   Clin Infect Dis. 2025 Jun 3:ciaf287. doi: 10.1093.
   PubMed    
   
   
   April 2025
8. JONES KM, Greene MT, Meddings J, Mantey J, et al
   Impact of a Collaboration-Focused Intervention to Prevent Healthcare-Associated Infections Before and During the Coronavirus Disease 2019 Pandemic.
   Clin Infect Dis. 2025 Apr 29:ciaf122. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. KAYE KS, Santerre Henriksen A
   Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infections: The Full Picture Combines Extensive Clinical Experience and Emerging Data.
   Clin Infect Dis. 2025 Apr 11:ciaf183. doi: 10.1093.
   PubMed    
   
   
   
10. SFEIR MM
    Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infections: Beyond Safety and Tolerability, More Clinical and Diagnostic Questions Remain Unanswered.
    Clin Infect Dis. 2025 Apr 11:ciaf182. doi: 10.1093.
    PubMed    
    
    
    March 2025
11. ADVANI SD, Thaden JT, Perez R, Stair SL, et al
    State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.
    Clin Infect Dis. 2025;80:e31-e42.
    PubMed     Abstract available
    
    
    
12. ADVANI SD, Thaden JT, Perez R, Stair SL, et al
    Executive Summary: State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women.
    Clin Infect Dis. 2025;80:491-493.
    PubMed    
    
    
    February 2025
13. KAYE KS, Santerre Henriksen A, Sommer M, Frimodt-Moller N, et al
    Safety and Tolerability of Pivmecillinam During More Than Four Decades of Clinical Experience: A Systematic Review.
    Clin Infect Dis. 2025;80:280-299.
    PubMed     Abstract available
    
    
    August 2024
14. STAUB M, Bennett J, Davis KW, Jansen JW, et al
    Population-Specific Urinalysis Parameters are Necessary to Improve Diagnostic Value for Urinary Tract Infection.
    Clin Infect Dis. 2024 Aug 19:ciae424. doi: 10.1093.
    PubMed    
    
    
    June 2024
15. WHITE AT, Vaughn VM, Petty LA, Gandhi TN, et al
    Development of Patient Safety Measures to Identify Inappropriate Diagnosis of Common Infections.
    Clin Infect Dis. 2024;78:1403-1411.
    PubMed     Abstract available
    
    
    April 2024
16. ADVANI SD, North R, Turner NA, Ahmadi S, et al
    Performance of Urinalysis Parameters in Predicting Urinary Tract Infection: Does One Size Fit all?
    Clin Infect Dis. 2024 Apr 26:ciae230. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. SHIELDS RK, Cheng WY, Kponee-Shovein K, Indacochea D, et al
    Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli-Causing Uncomplicated Urinary Tract Infection.
    Clin Infect Dis. 2024 Apr 4:ciae171. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
18. GUPTA V, Mastromarino P, Garg R
    Effectiveness of prophylactic oral and/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial.
    Clin Infect Dis. 2023 Dec 12:ciad766. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2023
19. 
    Correction to: Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
    Clin Infect Dis. 2023 Aug 17:ciad216. doi: 10.1093.
    PubMed    
    
    
    June 2023
20. BILSEN MP, Aantjes MJ, van Andel E, Stalenhoef JE, et al
    Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women.
    Clin Infect Dis. 2023;76:2070-2076.
    PubMed     Abstract available
    
    
    May 2023
21. GALLAGHER JC
    Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time.
    Clin Infect Dis. 2023;76:1613-1614.
    PubMed    
    
    
    April 2023
22. BULLOCH MN
    Optimal duration of therapy for inpatient complicated urinary tract infections remains undefined.
    Clin Infect Dis. 2023 Apr 6:ciad208. doi: 10.1093.
    PubMed    
    
    
    March 2023
23. DUNNE MW, Aronin SI, Das AF, Gupta J, et al
    Applying DOOR endpoint to randomized trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections.
    Clin Infect Dis. 2023 Mar 23:ciad149. doi: 10.1093.
    PubMed    
    
    
    February 2023
24. LAFAURIE M, Chevret S, Fontaine JP, Mongiat-Artus P, et al
    Antimicrobial for 7 or 14 days for febrile urinary tract infection in men: a multicenter noninferiority double blind placebo-controlled, randomized clinical trial.
    Clin Infect Dis. 2023 Feb 14:ciad070. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2023
25. MCATEER J, Lee JH, Cosgrove SE, Dzintars K, et al
    Defining the Optimal Duration of Therapy for Hospitalized Patients with Complicated Urinary Tract Infections and Associated Bacteremia.
    Clin Infect Dis. 2023 Jan 12:ciad009. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. KADRY N, Natarajan M, Bein E, Kim P, et al
    Discordant Clinical and Microbiological Outcomes are Associated with Late Clinical Relapse in Clinical Trials for Complicated Urinary Tract Infections (cUTI).
    Clin Infect Dis. 2023 Jan 10:ciad010. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
27. KARAKONSTANTIS S, Mpiliari E
    Fosfomycin oral step down for E. coli febrile urinary tract infections. Does the minimum inhibitory concentration (MIC) matter?
    Clin Infect Dis. 2022 Oct 20. pii: 6763736. doi: 10.1093.
    PubMed    
    
    
    September 2022
28. VAUGHN VM, Ratz D, Greene MT, Flanders SA, et al
    Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework.
    Clin Infect Dis. 2022;75:1063-1072.
    PubMed     Abstract available
    
    
    
29. RODRIGUEZ-BANO J, Gutierrez-Gutierrez B
    Opening a DOOR for pivotal studies: an example for complicated urinary tract infections.
    Clin Infect Dis. 2022 Sep 19. pii: 6705477. doi: 10.1093.
    PubMed    
    
    
    
30. DUNNE MW, Aronin SI, Das AF, Akinapelli K, et al
    Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3 Randomized Trial.
    Clin Infect Dis. 2022 Sep 7. pii: 6693482. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. DUNNE MW, Aronin SI, Das AF, Akinapelli K, et al
    Sulopenem For The Treatment of Complicated Urinary Tract Infection Including Pyelonephritis: A Phase 3 Randomized Trial.
    Clin Infect Dis. 2022 Sep 7. pii: 6693396. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
32. CLAEYS KC, Trautner BW, Leekha S, Coffey KC, et al
    Optimal Urine Culture Diagnostic Stewardship Practice-Results from an Expert Modified-Delphi Procedure.
    Clin Infect Dis. 2022;75:382-389.
    PubMed     Abstract available
    
    
    
33. HOWARD-ANDERSON J, Hamasaki T, Dai W, Collyar D, et al
    Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Complicated Urinary Tract Infection Clinical Trials.
    Clin Infect Dis. 2022 Aug 29. pii: 6678125. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. ADVANI SD, Sickbert-Bennett E, Moehring R, Cromer A, et al
    The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce.
    Clin Infect Dis. 2022 Aug 23. pii: 6673939. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
35. PATEL R, Polage CR, Dien Bard J, May L, et al
    Envisioning Future Urinary Tract Infection Diagnostics.
    Clin Infect Dis. 2022;74:1284-1292.
    PubMed     Abstract available
    
    
    December 2021
36. VAUGHN VM, Gandhi TN, Chopra V, Petty LA, et al
    Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study.
    Clin Infect Dis. 2021;73:e4499-e4506.
    PubMed     Abstract available
    
    
    September 2021
37. OUATTARA M, Bassa FK, Diakite NR, Hattendorf J, et al
    Effectiveness of Four Different Interventions against Schistosoma haematobium in a Seasonal Transmission Setting of Cote d'Ivoire: A Cluster Randomized Trial.
    Clin Infect Dis. 2021 Sep 14. pii: 6369964. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
38. BAKER MA, Sands KE, Huang SS, Kleinman K, et al
    The Impact of COVID-19 on Healthcare-Associated Infections.
    Clin Infect Dis. 2021 Aug 9. pii: 6346721. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
39. KAYE KS, Gupta V, Mulgirigama A, Joshi AV, et al
    Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011-2019: Rising ESBL Strains and Impact on Patient Management.
    Clin Infect Dis. 2021 Jun 18. pii: 6304915. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Urinary Tract Infection is free of charge.